Skip navigation
Skip navigation

Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2

Watterson, Daniel; Wijesundara, Danushka K; Modhiran, Naphak; Mordant, F; Li, Jerry; Avumegah, Michael S; McMillan, Christopher L D; Lackenby, Julia A; Guilfoyle, Kate; van Amerongen, Geert; Stittelaar, Koert; Ranasinghe, Charani


Objectives: Efforts to develop and deploy effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue at pace. Here, we describe rational antigen design through to manufacturability and vaccine efficacy of a prefusion-stabilised spike (S) protein, Sclamp, in combination with the licensed adjuvant MF59 ‘MF59C.1’ (Seqirus, Parkville, Australia). Methods: A panel recombinant Sclamp proteins were produced in Chinese hamster ovary and screened in vitro to select...[Show more]

CollectionsANU Research Publications
Date published: 2021
Type: Journal article
Source: Clinical and Translational Immunology
DOI: 10.1002/cti2.1269
Access Rights: Open Access


File Description SizeFormat Image
Clin Trans Imm - 2021 - Watterson.pdf4.83 MBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator